We are passionate to bring to market our OncoSIGNal pathway activity profiling technology contributing to a better understanding of disease mechanisms in oncology. OncoSIGNal enables next generation precision medicine by translating molecular data into functional cell behavior.

  • revolutionizing precision medicine

Board of Directors

Allan May

Chairman - Life Science Angels

Harrold van Barlingen

Thuja Capital

Shaun Rodriguez

Casdin Capital

Mark Oldroyd

Independent Board Member

Paul van de Wiel

CEO InnoSIGN

Jeroen Siemes

Observer BOM

Benno Tieke

Observer Philips

Management Team

Paul van de Wiel

Chief Executive Officer

Sigi Neerken

Chief Business Officer

Eveline den Biezen

Chief Technology Officer

Anke Pierik

Chief Operating Officer